$ENVA

GOODYEAR WILLIAM M sold $976K of ENVA

GOODYEAR WILLIAM M sold 5,983 shares of Enova International, Inc. (ENVA) at $163.13 ($0.98M total) on 2026-06-01.

Original reporting
SEC EDGAR · GOODYEAR WILLIAM M
Published Jun 3, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 3, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ENVA
Neutral
medium confidence
Mentioned
$ENVA
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENVANeutralLow
01

Why it matters

This provides incremental sentiment information (insider reducing exposure), but it does not change ENVA’s fundamentals based on the article alone.

02

Market read

Traders may monitor for additional insider activity or confirm whether the sale is part of a broader pattern, but there is no direct fundamental catalyst here.

03

What to watch

The article doesn’t specify whether the director’s broader selling program exists beyond this transaction; also, insider sales often have limited predictive power without clustering or follow-on disclosures.

Relevance 6/10Novelty 6/10Timing: SEC Form 4 filed June 3 for a June 1 sale

Background

The filing is an SEC Form 4 insider transaction: director GOODYEAR WILLIAM M sold ENVA shares on June 1; the filing was made June 3.

Company-level read

Ticker impact

$ENVANeutralMedium confidence
Context

Enova director GOODYEAR WILLIAM M sold 5,983 shares in an open-market transaction worth about $976K, disclosed via SEC Form 4.

Expected impact

Low near-term impact; any reaction is likely limited unless follow-on selling or new fundamentals emerge.

Evidence & confidence

This is an ownership-change disclosure (Form 4) with modest dollar value relative to typical market caps; no new company-specific operational or financial information is provided.

Market effects

Minimal—this is company-specific insider activity with no stated sector/regulatory trigger.

None indicated.

None indicated.

Counterpoint

The sale may be routine liquidity management rather than a negative view, especially with no accompanying negative news in the filing.

Key entities

  • Enova International, Inc.

    Subject of the insider transaction disclosure; director sold shares open-market.

  • GOODYEAR WILLIAM M

    Director who executed the reported sale of ENVA shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ENVAMed

Citizens raises Enova stock price target on strong growth outlook

Citizens raised its price target for Enova International (NYSE:ENVA) to $220 from $215, citing strong growth and stable credit quality. The company reported 30%+ originations growth and 30%+ EPS growth for multiple quarters. Enova's stock has gained 55% over the past year, but may be overvalued according to InvestingPro's Fair Value analysis. Citizens also increased its 2027 adjusted EPS estimate to $22.03 from $21.47, expecting more aggressive share buybacks.

$ENVAMedAI 8/10

Enova International Inc (ENVA) Q3 2026 Earnings Call Highlights: Revenue Tops $1 Billion

Enova International Inc (ENVA) reported Q3 2026 revenue exceeding $1 billion, up 26% YoY, with adjusted EPS increasing 33% to $4.48. Originations grew 31% YoY to $2.6 billion, marking 12 consecutive quarters of at least 20% growth. The company noted increased marketing expenses and SMB delinquencies, while withdrawing bank applications. Management expects Q4 2026 revenue to rise 25% YoY with stable margins.

$ENVAMedAI 8/10

Enova Tops $1 Billion Quarterly Revenue as Online Lending

Enova reported Q3 2026 revenue of $1.1 billion, up 26% YoY, with originations and adjusted EPS also rising significantly. Net charge-off ratio improved to 8.1%. The company's portfolio reached $5.9 billion, with small business products comprising 68%. Enova withdrew its bank regulatory applications for Grasshopper Bancorp acquisition, citing regulatory misalignment, but expects continued growth.

$ENVAMed

What Enova International (ENVA) Said on Its Q3 Earnings Call

Enova International (ENVA) reported Q3 improvements in net charge-off ratios and revenue margins, with consolidated net revenue margin at 61%. The company expects Q4 margins between 55% and 60%. Marketing expenses rose to 23% of revenue, supporting growth. Enova has $1.3B in liquidity and repurchased 243,000 shares. It forecasts 25% revenue growth and 30-35% adjusted EPS increase for Q4. The company is exploring new product opportunities in consumer and small-business lending.

$ENVAMedAI 8/10

Enova (ENVA) Q3 2026 Earnings Call Transcript

Enova (ENVA) reported Q3 2026 earnings with 26% revenue growth to over $1 billion, driven by 30% portfolio growth. Consumer and small business originations increased 37% and 28% respectively. Adjusted EPS rose 33%. Net charge-off rates improved, with the consolidated rate at 8.1%. The company expects strong Q4 results, citing resilient macroeconomic conditions and consumer spending.